Page last updated: 2024-08-21

psilocybin and Parkinson Disease

psilocybin has been researched along with Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andel, D; Cahn, BR; Carter, OL; Kometer, M; Vollenweider, FX	1

Other Studies

1 other study(ies) available for psilocybin and Parkinson Disease

Article	Year
The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations. Biological psychiatry, 2011, Mar-01, Volume: 69, Issue:5 Topics: Adult; Cluster Analysis; Consciousness Disorders; Dose-Response Relationship, Drug; Electroencephalography; Female; Hallucinogens; Humans; Male; Neuropsychological Tests; Occipital Lobe; Parkinson Disease; Perceptual Closure; Photic Stimulation; Psilocybin; Psychometrics; Reaction Time; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Schizophrenia; Serotonin Receptor Agonists; Visual Cortex	2011

Article

Year

The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations.

Biological psychiatry, 2011, Mar-01, Volume: 69, Issue:5

Topics: Adult; Cluster Analysis; Consciousness Disorders; Dose-Response Relationship, Drug; Electroencephalography; Female; Hallucinogens; Humans; Male; Neuropsychological Tests; Occipital Lobe; Parkinson Disease; Perceptual Closure; Photic Stimulation; Psilocybin; Psychometrics; Reaction Time; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Schizophrenia; Serotonin Receptor Agonists; Visual Cortex

2011